press release-pg电子官方

pg电子官方-pg电子游戏平台
about us
about us
green valley is an innovative chinese pharmaceutical company that pioneers carbohydrate drugs development and manufacturing in the world.
about green valley
our business
mission & vision
our culture
code of business ethics
gv-971
gv-971
here you can get access to more information of gv-971.
products
news reports
research highlights
milestones
scientific research information
scientific research information
originality is the soul of our innovation in scientific research. we are devoted to developing drugs and healthcare solutions that patients are in the greatest need of.
life sciences innovation
research parteners
news
news
here you can get access to the latest news reports of green valley.
press releases
news reports
social responsibility
careers
apart from the competitive compensation & benefits programs, we have developed a detailed benefits and perks scheme. we respect, appreciate and reward the contributions of every employee for their hard work and dedication.
salary and benefits
contact us
contact us
media contacts
pg电子官方-pg电子游戏平台
press releases

feature | gv-971 global multi-center phase iii clinical trial

novel drug treatment shows improved cognition in a phase 3 clinical trial in persons with mild-to-mo

gv-971 gets included in china national reimbursement drug list

gv-971 global phase iii clinical trial completes first patient dosed in greater china

sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids
all
all
2022
2021
2020
2019
2018
2017
2015
07-31
2017
2017-07-31
expert academician workstation and practice base for postgraduate students enrolled in the professional master's programs at shenyang pharmaceutical university settle in at the green valley
on july 31, 2017, the opening ceremony of the liaoning benxi "expert academician workstation" and the "practice base for postgraduate students enrolled in the professional master's programs at shenyang pharmaceutical university" were h
07-05
2017
2017-07-05
coronary microcirculation intervention was expected to bring a new perspective to precise treatment of coronary artery disease
on july 5, an academic symposium titled“meticulous and innovative care”on disturbances of coronary microcirculation, hosted by the china cardiovascular association and china heart house (suzhou industrial park), and co-organized by shanghai green valley p
04-17
2015
2015-04-17
benxi municipal government and green valley signed a strategic cooperation agreement
on april 17, 2015, a team of government leaders, led by gao hongbin, mayor of benxi city, inspected the green valley pharmaceutical company, and signed a strategic cooperation agreement with the company management. mayor gao, yu hai, municipal deputy cadr
03-20
2015
2015-03-20
international summit on the hotspots of cardiovascular diseases (myocardial microcirculation) held in beijing
on march 20, 2015, the “international expert summit on the hotspots and new progress in cardiovascular diseases and myocardial microcirculation” sponsored by the chinese journal of cardiology and supported by green valley pharmaceutical co., ltd. was held
03-15
2015
2015-03-15
the first symposium of clinical trials on alzheimer's diseases was successfully held in shanghai
on march 15, 2015, green valley pharmaceutical co., ltd. and the shanghai institute of materia medica at chinese academy of sciences hosted the first symposium of clinical trials on alzheimer's disease (ad) of shanghai in kerry hotel pudong shanghai.
03-01
2015
2015-03-01
shanghai green valley (benxi) and shenyang pharmaceutical university signed a strategic cooperation agreement
on march 1, 2015, shanghai green valley (benxi) pharmaceutical co., ltd. and the shenyang pharmaceutical university signed a strategic, cooperative agreement.
网站地图